Associated Papers
"Eculizumab First" in the Management of Posttransplant Thrombotic Microangiopathy.
Maritati F et al.
Kidney International Reports, 2024
Complement gene variant effect on relapse of complement-mediated thrombotic microangiopathy after eculizumab cessation.
Acosta-Medina AA et al.
Blood Advances, 2023
35533258 (PubMed )
Supplement: BLOODA_ADV-2021-006416-mmc1.pdf
Select a paper to view details